Summary:
- Teladoc Health Inc. (TDOC, Financial) will announce Q1 2025 earnings on April 30, post-market.
- Analysts predict a 59.12% upside potential with an average target price of $10.26.
- GuruFocus estimates suggest a significant 236.28% upside based on GF Value.
Upcoming Q1 2025 Earnings Announcement
Teladoc Health Inc. (TDOC), a leader in virtual care solutions, is scheduled to release its first-quarter 2025 earnings results on April 30, after the closing bell. Investors can tune in to an in-depth discussion of these results during a 4:30 p.m. ET conference call. The call will be accessible via phone for U.S. investors and through an online webcast for international participants.
Analyst Price Targets and Recommendations
The latest insights from 19 Wall Street analysts set the one-year price target for Teladoc Health Inc. at an average of $10.26. This estimate spans a high of $14.00 and a low of $8.00, demonstrating a potential upside of 59.12% from its current trading price of $6.45. For an in-depth analysis, visit the Teladoc Health Inc. (TDOC, Financial) Forecast page.
Based on consensus ratings from 26 brokerage firms, the average brokerage recommendation for Teladoc Health Inc. is 2.8, which aligns with a "Hold" strategy. This rating scale ranges from 1 (Strong Buy) to 5 (Sell).
Understanding the GF Value Estimate
According to GuruFocus estimates, the GF Value for Teladoc Health Inc. in the coming year is projected at $21.69. This indicates a remarkable upside potential of 236.28% from its current price point of $6.45. The GF Value is derived from historical multiples at which the stock has traded, coupled with past growth metrics and anticipated business performance. For more comprehensive data, please see the Teladoc Health Inc. (TDOC, Financial) Summary page.
